Concepedia

Publication | Open Access

Trifluridine–Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer

DOIFull Paper Access

375

Citations

28

References

2023

Year

Gerald W. Prager, Marwan Fakih, Fortunato Ciardiello, Eric Van Cutsem, Élena Elez, Felipe Melo Cruz, Lucjan Wyrwicz, Daniil Stroyakovskiy, Zsuzsanna Pápai, Pierre-Guillaume Poureau,
New England Journal of Medicine

Abstract

Among patients with refractory metastatic colorectal cancer, treatment with FTD-TPI plus bevacizumab resulted in longer overall survival than FTD-TPI alone. (Funded by Servier and Taiho Oncology; SUNLIGHT ClinicalTrials.gov number, NCT04737187; EudraCT number, 2020-001976-14.).

References

YearCitations

Page 1